Haoxi Health Technology Announces Preliminary FY24 Revenue Of ~$48.52M Up From $28.23M YoY
Portfolio Pulse from Benzinga Newsdesk
Haoxi Health Technology Limited (HAO) reports a significant increase in preliminary FY24 revenue to approximately $48.52 million, up 72% from FY23. The growth is attributed to strategic development in online advertising solutions, particularly short video formats and news feed ads. Gross profit and net income also saw substantial increases.
October 07, 2024 | 12:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Haoxi Health Technology Limited (HAO) reports a 72% increase in preliminary FY24 revenue to approximately $48.52 million, driven by strategic advancements in online advertising solutions. Gross profit and net income also saw significant growth.
The significant increase in revenue, gross profit, and net income indicates strong financial performance and effective strategic initiatives in online advertising. This positive financial outlook is likely to boost investor confidence and positively impact HAO's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100